Revitalize Aesthetics & Wellness
840 State Route 96 · Warner Robins, GA 31088
4.9(34 Google reviews · 3 in past year)
Accepts insurance
Listing updated Oct 2, 2026
HealthNow LLC.
HealthNow LLC. · 112 Tommy Stalnaker Drive · Warner Robins, GA 31088
5.0· 27 Google reviews
Listing updated October 2, 2026
Retatrutide outlook for this practice
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- GLP-1 medications named on site
- Medically supervised weight loss
About this practice
HealthNow LLC. is a telemedicine practice in Warner Robins, Georgia. Its website describes remote visits for consultations and acute issues, along with a weight-loss program offering semaglutide and tirzepatide injections, and its pages also cover testosterone replacement therapy. Google shows a 5.0-star rating across 27 reviews dating back to 2024, with none in the past year; reviewers most often mention the staff, results and the providers' knowledge.
Services & access
| Advertises semaglutide today | Yes |
| Advertises tirzepatide today | Yes |
| Telehealth visits | Yes |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
★ 5.0
Google rating · 27 reviews
1
reviews mention GLP-1 medications
5
reviews mention weight loss
Counts computed by RetaMaps from public Google reviews; most recent review 2024-10-14. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 27 Google reviews. Of the 27 reviews we analyzed, 27 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Friendly, helpful staff7 reviews
- Weight-loss results6 reviews
- Knowledgeable, professional providers6 reviews
Common complaints
No negative reviews among those we analyzed.
5★
26
4★
1
3★
0
2★
0
1★
0
Most recent Google reviews
Jamie R.★★★★★2024-10-14Chase has gone above and beyond for my family. When my husband was having issues with his throat and our so called family doctor would not return any of our phone calls we went to chase for help. He made sure my husband went to the right people. I cannot thank chase enough for doing this for me and my family and my husband for the fact that we thought the worse.
Bryce G.★★★★★2024-10-09Nothing but positive things to say. Chase was extremely helpful in providing clarification.
jesse r.★★★★★2024-10-04Best service in town! They truly care about your well-being and take the time to listen to you.
Robbin A.★★★★★2024-09-12Awesome place to do business,great customer service!
Dustin S.★★★★★2024-08-27Awesome!!!
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in Warner Robins
Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs